[PDF][PDF] Screening for cervical cancer: a systematic evidence review for the US Preventive Services Task Force

KK Vesco, EP Whitlock, M Eder, J Lin… - Lancet …, 2011 - uspreventiveservicestaskforce.org
Purpose: We conducted this targeted systematic evidence review of five key questions to
assist the US Preventive Services Task Force (USPSTF) in updating its 2003 …

Comparison of use of vaginal HPV self-sampling and offering flexible appointments as strategies to reach long-term non-attending women in organized cervical …

L Darlin, C Borgfeldt, O Forslund, E Hénic… - Journal of Clinical …, 2013 - Elsevier
Background Many cervical cancers occur among women who have not attended cervical
screening. Strategies to reach non-attending women may improve the effectiveness of …

Cervical adenocarcinoma: moving towards better prevention

M Seoud, WAA Tjalma, V Ronsse - Vaccine, 2011 - Elsevier
OBJECTIVE: Although cervical screening has led to a significant decline of invasive cervical
cancer (ICC) in developed countries, it remains the third leading cause of cancer in women …

[HTML][HTML] Gut microbiota signatures in tumor, para-cancerous, normal mucosa, and feces in colorectal cancer patients

Y Li, H Cao, B Fei, Q Gao, W Yi, W Han… - Frontiers in Cell and …, 2022 - frontiersin.org
Background: Association studies have linked microbiome alterations with colorectal cancer
(CRC). However, differences in tumor, para-cancerous, normal mucosal, and fecal …

[HTML][HTML] Is the HPV-test more cost-effective than cytology in cervical cancer screening? An economic analysis from a middle-income country

DB Vale, MT Silva, MG Discacciati, I Polegatto… - Plos one, 2021 - journals.plos.org
Objective To report a modelling study using local health care costs and epidemiological
inputs from a population-based program to access the cost-effectiveness of adopting hrHPV …

[HTML][HTML] Never and under cervical cancer screening in Switzerland and Belgium: trends and inequalities

V Jolidon, V De Prez, B Willems, P Bracke, S Cullati… - BMC Public Health, 2020 - Springer
Background Research on inequalities in cervical cancer screening (CCS) participation has
overlooked the distinction between 'never-'and 'under-screeners' while different …

[HTML][HTML] Validation of proposed prostate cancer biomarkers with gene expression data: a long road to travel

A Amaro, AI Esposito, A Gallina, M Nees… - Cancer and Metastasis …, 2014 - Springer
Biomarkers are important for early detection of cancer, prognosis, response prediction, and
detection of residual or relapsing disease. Special attention has been given to diagnostic …

[HTML][HTML] In Vitro and In Vivo Study of Combined Effect of Some Algerian Medicinal Plants and Probiotics against Helicobacter pylori

B Hasna, H Houari, D Koula, S Marina, U Emilia… - Microorganisms, 2023 - mdpi.com
Helicobacter pylori causes gastritis, peptic ulcers and gastric cancer and affects more than
half of the world's population. Although this infection can have serious consequences, no …

Trends in cervical cancer incidence and mortality in the Baltic countries, Bulgaria and Romania

M Arbyn, J Antoine, M Mägi, G Smailyte… - … Journal of Cancer, 2011 - Wiley Online Library
The burden of cervical cancer varies considerably in the European Union (EU). In this
article, we describe trends in incidence of and mortality from this cancer in the two most …

The importance of socio-economic variables in cancer screening participation: a comparison between population-based and opportunistic screening in the EU-15

B Walsh, M Silles, C O'Neill - Health policy, 2011 - Elsevier
OBJECTIVES: To investigate differences in participation with breast and cervical cancer
screening related to individual socio-economic characteristics, across population-based …